1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of genomic biomarkers of response to immunotherapy in sarcoma
    Meeting Abstract

    Trabucco, S. E.; Ali, S. M.; Sokol, E.; Betzig Schrock, A.; Albacker, L. A.; Chung, J.; Feldman Xavier, M.; Disel, U.; Miller, V. A.; Ross, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma
    Meeting Abstract

    Ravi, V.; Brohl, A. S.; Chawla, S. P.; Attia, S.; Riedel, R. F.; Liebner, D. A.; Thornton, K. A.; Mallick, A. B.; Mehta, C. R.; Liu, L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of endoglin-expressing CTCs in patients enrolled in an adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS)
    Meeting Abstract

    Ravi, V.; Brohl, A. S.; Chawla, S. P.; Attia, S.; Riedel, R. F.; Liebner, D. A.; Thornton, K. A.; Mallick, A. B.; Davis, D. W.; Cervantes, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic subtypes of angiosarcoma: A comprehensive genomic profiling (CGP) study
    Meeting Abstract

    Ravi, V.; Trabucco, S. E.; Gounder, M. M.; Sokol, E.; Disel, U.; Frampton, G. M.; Millis, S. Z.; Schrock, A. B.; Chung, J.; Miller, V. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Projecting long term survival for avelumab in refractory Merkel cell carcinoma
    Meeting Abstract

    Phatak, H.; Proskorovsky, I.; Lanitis, T.; Ambavane, A.; Hunger, M.; D'Angelo, S. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma
    Meeting Abstract

    Mowery, Y. M.; Ballman, K. V.; Riedel, R. F.; Brigman, B. E.; Attia, S.; Meyer, C. F.; Schuetze, S.; Burgess, M. A.; Chmielowski, B.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neutropenia and response to single agent palbociclib
    Meeting Abstract

    McAndrew, N. P.; Dickson, M. A.; Clark, A. S.; Troxel, A.; Colameco, C.; Gallagher, M.; Gramlich, K.; Zafman, K.; Vaughn, D. J.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled crossover study
    Meeting Abstract

    Gounder, M. M.; Somaiah, N.; Attia, S.; Chawla, S. P.; Villalobos, V. M.; Chmielowski, B.; Burgess, M. A.; Schwartz, G. K.; Riedel, R. F.; von Mehren, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save